Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Merck & Co - total revenue 2006-2019

The revenue of Merck & Co. increased in 2019, rising from 42.3 billion U.S. dollars in 2018 to approximately 46.8 billion U.S. dollars over the year. Sales of the company’s animal health products generated an estimated nine percent share of total revenue.

Revenues lifted by sales of cancer treatments

The majority of Merck’s revenue comes from its pharmaceutical segment, which includes human health and vaccine products. The company’s oncology franchise, which is dedicated to the study of cancer, generated the most pharmaceutical revenue in 2019. Sales of Keytruda, a drug used to fight cancer, were particularly strong during the year – revenue increased by nearly four billion U.S. dollars between 2018 and 2019.

The importance of investing in innovation

Higher sales of vaccine products also contributed to the increase in Merck’s revenue in 2019, primarily driven by a 19 percent rise in sales of Gardasil/Gardasil 9, which can help in the prevention of certain cancers. Developing commercially successful products, such as Keytruda and Gardasil, is essential if Merck & Co. want to compete in the industry. The company continues to recognize the importance of research and development and has annually invested around ten billion U.S. dollars in the search for innovative medicines over the last few years.

Total revenue of Merck & Co. from 2006 to 2019

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2020

Region

Worldwide

Survey time period

2006 to 2019

Supplementary notes

Values for 2006-2014 were taken from previous annual financial reports.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Merck & Co."

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.